SpeechDx Featured in Alzheimer's & Dementia Journal for AI Speech Marker Research

June 23, 2026
A paper in Alzheimer's & Dementia highlights SpeechDx's role in developing AI tools that use speech patterns to detect early cognitive decline and support personalized Alzheimer's care.

SpeechDx was featured in a new paper published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, announced in a press release. The publication explores how artificial intelligence and digital speech-based markers are being used to advance early detection and monitoring of Alzheimer's disease.

The paper outlines how scalable digital biomarkers can help identify cognitive changes before clinical symptoms appear. It also highlights the SpeechDx initiative, which collects longitudinal speech data to support the creation of tools for predicting cognitive decline and enabling earlier intervention.

According to the release, SpeechDx aims to accelerate the development of digital markers that guide more personalized care and improve the ability to assess Alzheimer's risk in its earliest stages.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Governing the Future: A Strategic Framework for AI Adoption in Financial Institutions

This whitepaper explores the transformative impact of artificial intelligence on the financial industry, focusing on the governance challenges and regulatory demands faced by banks. It provides a strategic framework for AI adoption, emphasizing the importance of a unified AI approach to streamline compliance and reduce operational costs. The document offers actionable insights and expert recommendations for banks with fewer than 2,000 employees to become leaders in compliant, customer-centric AI.

Read more